Assistant Professor University of Florida Orlando, Florida
1. Using organ-on-a-chip technology to model CAR-T cell therapies and bi-specific antibodies (15 minutes) o Holistic organ-on-a-chip model to assess recruitment, target-specific efficacy and fitness of CAR-T cell therapies o Modeling cytokine release syndrome in vitro
Learning Objectives:
Discuss cutting-edge developments in applying microphysiological systems (aka organ-on-a-chip) to develop CAR-T therapies.
Discuss the benefitis of assessing CAR T cell recruitment, migration and fitness using a dynamic in vitro model using microfluidics.
To foster collaboration between computational biologists, pharmacologists, and clinical researchers.